CommonPass is a standardised global identification framework that makes it possible for travellers to document and share their Covid-19 testing status and vaccination history. Ensuring that entrants meet all Covid-19 related immigration regulations, the system removes barriers to and expedites processing of international travel while also protecting user privacy.
"At ANA, we are constantly looking for ways to make the travel experience safer and more convenient," said Juichi Hirasawa, Senior Vice-President of ANA Corporate Planning. "Our trials of the CommonPass Health application will help us to ensure that these procedures will enable us to simplify international travel while also protecting passenger privacy."
CommonPass streamlines check-in procedures
CommonPass verifies that an individual's lab test results or vaccination records come from a trusted source and meet the health screening requirements of the country they want to enter. Throughout the entire process, personal health information stays in the user's control. CommonPass helps customs and immigration personnel access pre-departure PCR test results, linking them to the name and travel document numbers of the user while also confirming that the negative results were recorded within the prescribed timeframe and conducted at accredited laboratories. CommonPass also streamlines airport check-in procedures.
During this trial, ANA will verify the effectiveness of tests and check-in procedures at Haneda Airport, using the information it gathers to improve the process. Meanwhile, US low-cost airline JetBlue has already begun using the CommonPass platform on flights to Aruba.